105 related articles for article (PubMed ID: 1506869)
1. Immunoreactive parvalbumin concentrations in parahippocampal gyrus decrease in patients with Alzheimer's disease.
Inaguma Y; Shinohara H; Inagaki T; Kato K
J Neurol Sci; 1992 Jul; 110(1-2):57-61. PubMed ID: 1506869
[TBL] [Abstract][Full Text] [Related]
2. Concentrations of several proteins characteristic of nervous tissue in cerebral cortex of patients with Alzheimer's disease.
Kato K; Kurobe N; Suzuki F; Morishita R; Asano T; Sato T; Inagaki T
J Mol Neurosci; 1991; 3(2):95-9. PubMed ID: 1814396
[TBL] [Abstract][Full Text] [Related]
3. Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET.
Yamaguchi S; Meguro K; Itoh M; Hayasaka C; Shimada M; Yamazaki H; Yamadori A
J Neurol Neurosurg Psychiatry; 1997 Jun; 62(6):596-600. PubMed ID: 9219745
[TBL] [Abstract][Full Text] [Related]
4. Parvalbumin-immunoreactive neurons in the hippocampal formation of Alzheimer's diseased brain.
Brady DR; Mufson EJ
Neuroscience; 1997 Oct; 80(4):1113-25. PubMed ID: 9284064
[TBL] [Abstract][Full Text] [Related]
5. Appearance of parvalbumin-specific immunoreactivity in the cerebral cortex and hippocampus of the developing rat and gerbil brain.
Seto-Ohshima A; Aoki E; Semba R; Emson PC; Heizmann CW
Histochemistry; 1990; 94(6):579-89. PubMed ID: 2279955
[TBL] [Abstract][Full Text] [Related]
6. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment].
Cao Q; Jiang K; Liu Y; Zhang M; Xiao S; Zuo C; Huang H
Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1613-6. PubMed ID: 12667368
[TBL] [Abstract][Full Text] [Related]
7. Parvalbumin-immunoreactive dystrophic neurites and aberrant sprouts in the cerebral cortex of patients with Alzheimer's disease.
Ferrer I; Zújar MJ; Rivera R; Soria M; Vidal A; Casas R
Neurosci Lett; 1993 Aug; 158(2):163-6. PubMed ID: 8233090
[TBL] [Abstract][Full Text] [Related]
8. Cortical distribution of gangliosides in Alzheimer's disease.
Kracun I; Kalanj S; Talan-Hranilovic J; Cosovic C
Neurochem Int; 1992 Apr; 20(3):433-8. PubMed ID: 1304338
[TBL] [Abstract][Full Text] [Related]
9. Quantification of regional glial fibrillary acidic protein levels in Alzheimer's disease.
Ross GW; O'Callaghan JP; Sharp DS; Petrovitch H; Miller DB; Abbott RD; Nelson J; Launer LJ; Foley DJ; Burchfiel CM; Hardman J; White LR
Acta Neurol Scand; 2003 May; 107(5):318-23. PubMed ID: 12713522
[TBL] [Abstract][Full Text] [Related]
10. Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients.
Dedman DJ; Treffry A; Candy JM; Taylor GA; Morris CM; Bloxham CA; Perry RH; Edwardson JA; Harrison PM
Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):509-14. PubMed ID: 1445209
[TBL] [Abstract][Full Text] [Related]
11. N-methyl-D-aspartate receptor complex in the hippocampus of elderly, normal individuals and those with Alzheimer's disease.
Ułas J; Brunner LC; Geddes JW; Choe W; Cotman CW
Neuroscience; 1992 Jul; 49(1):45-61. PubMed ID: 1407551
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin messenger RNA-containing neurons in Alzheimer's disease: an in situ hybridization study in hippocampus, parahippocampal cortex and frontal cortex.
Dournaud P; Cervera-Pierot P; Hirsch E; Javoy-Agid F; Kordon C; Agid Y; Epelbaum J
Neuroscience; 1994 Aug; 61(4):755-64. PubMed ID: 7838375
[TBL] [Abstract][Full Text] [Related]
13. Volumes of lateral temporal and parietal structures distinguish between healthy aging, mild cognitive impairment, and Alzheimer's disease.
Hänggi J; Streffer J; Jäncke L; Hock C
J Alzheimers Dis; 2011; 26(4):719-34. PubMed ID: 21709375
[TBL] [Abstract][Full Text] [Related]
14. Atrophy of the hippocampus, parietal cortex, and insula in Alzheimer's disease: a volumetric magnetic resonance imaging study.
Foundas AL; Leonard CM; Mahoney SM; Agee OF; Heilman KM
Neuropsychiatry Neuropsychol Behav Neurol; 1997 Apr; 10(2):81-9. PubMed ID: 9150507
[TBL] [Abstract][Full Text] [Related]
15. Parvalbumin-immunoreactive neurons in the cortex in Pick's disease.
Arai H; Noguchi I; Makino Y; Kosaka K; Heizmann CW; Iizuka R
J Neurol; 1991 Jul; 238(4):200-2. PubMed ID: 1895150
[TBL] [Abstract][Full Text] [Related]
16. Hippocampal excitatory amino acid receptors in elderly, normal individuals and those with Alzheimer's disease: non-N-methyl-D-aspartate receptors.
Geddes JW; Ułas J; Brunner LC; Choe W; Cotman CW
Neuroscience; 1992 Sep; 50(1):23-34. PubMed ID: 1328933
[TBL] [Abstract][Full Text] [Related]
17. [Change of cerebral metabolism rate of glucose of cerebral white matter in Alzheimer's disease: a study with statistical parametric mapping software].
Cao QY; Guo WH; Yang HL; Shen DW; Zhao P; Jiang KD; Zhang MY; Xiao SF
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2777-9. PubMed ID: 18167271
[TBL] [Abstract][Full Text] [Related]
18. Chandelier cell axons identified by parvalbumin-immunoreactivity in the normal human temporal cortex and in Alzheimer's disease.
Fonseca M; Soriano E; Ferrer I; Martinez A; Tuñon T
Neuroscience; 1993 Aug; 55(4):1107-16. PubMed ID: 8232900
[TBL] [Abstract][Full Text] [Related]
19. Regionally selective alterations in G protein subunit levels in the Alzheimer's disease brain.
O'Neill C; Wiehager B; Fowler CJ; Ravid R; Winblad B; Cowburn RF
Brain Res; 1994 Feb; 636(2):193-201. PubMed ID: 8012802
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the severity of neuropathologic changes in familial and sporadic Alzheimer's disease.
Nochlin D; van Belle G; Bird TD; Sumi SM
Alzheimer Dis Assoc Disord; 1993; 7(4):212-22. PubMed ID: 8305189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
